Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

TCRXTCRX
20 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in TSCAN THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 2.8M shares of TCRX (TSCAN THERAPEUTICS INC), worth $2.7M as of 2026-Q2. TCRX represents 0.0% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$2.7M

Current Shares

2.8M

Total Value Change

-$9.2M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.8M
0.0%
$2.7M0.0%$0.98
0
2026-Q1
Unchanged
2.8M
0.0%
$2.8M0.0%$1.03
0
2025-Q4
Unchanged
2.8M
0.0%
$2.8M0.0%$1.03
0
2025-Q3
Unchanged
2.8M
0.0%
$5.1M0.0%$1.74
0
2025-Q2
Unchanged
2.8M
0.0%
$4M0.0%$1.40
0
2025-Q1
Unchanged
2.8M
0.0%
$3.8M0.0%$1.35
0
2024-Q4
Unchanged
2.8M
0.0%
$8.5M0.1%$3.00
0
2024-Q3
Unchanged
2.8M
0.0%
$13.9M0.1%$5.04
0
2024-Q2
Unchanged
2.8M
0.0%
$16.3M0.2%$5.85
0
2024-Q1
Unchanged
2.8M
0.0%
$22.1M0.3%$7.94
0
2023-Q4
Unchanged
2.8M
0.0%
$16.2M0.2%$5.83
0
2023-Q3
Unchanged
2.8M
0.0%
$7.1M0.0%$2.56
0
2023-Q2
Unchanged
2.8M
0.0%
$7M0.0%$2.54
0
2023-Q1
Unchanged
2.8M
0.0%
$5.8M0.0%$2.57
0
2022-Q4
Unchanged
2.8M
0.0%
$4.3M0.0%$1.55
0
2022-Q3
Unchanged
2.8M
0.0%
$8.5M0.1%$3.13
0
2022-Q2
Increased
2.8M
+95.4%
$8.8M0.0%$3.10
44
2022-Q1
Unchanged
1.4M
0.0%
$4M0.0%$2.91
0
2021-Q4
Unchanged
1.4M
0.0%
$6.4M0.0%$4.83
0
2021-Q3
New
1.4M
-
$11.9M0.1%$8.59
39

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used